Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

Differential Tolerance to FTY720-Induced Antinociception in Acute Thermal and Nerve Injury Mouse Pain Models: Role of Sphingosine-1-Phosphate Receptor Adaptation.

Sim-Selley LJ, Wilkerson JL, Burston JJ, Hauser KF, McLane V, Welch SP, Lichtman AH, Selley DE.

J Pharmacol Exp Ther. 2018 Sep;366(3):509-518. doi: 10.1124/jpet.118.248260. Epub 2018 Jun 26.

PMID:
29945931
2.

Therapeutic Benefit for Late, but Not Early, Passage Mesenchymal Stem Cells on Pain Behaviour in an Animal Model of Osteoarthritis.

Chapman V, Markides H, Sagar DR, Xu L, Burston JJ, Mapp P, Kay A, Morris RH, Kehoe O, El Haj AJ.

Stem Cells Int. 2017;2017:2905104. doi: 10.1155/2017/2905104. Epub 2017 Dec 24.

3.

Manganese-enhanced magnetic resonance imaging depicts brain activity in models of acute and chronic pain: A new window to study experimental spontaneous pain?

Devonshire IM, Burston JJ, Xu L, Lillywhite A, Prior MJ, Watson DJG, Greenspon CM, Iwabuchi SJ, Auer DP, Chapman V.

Neuroimage. 2017 Aug 15;157:500-510. doi: 10.1016/j.neuroimage.2017.06.034. Epub 2017 Jun 17.

4.

Targeting the D Series Resolvin Receptor System for the Treatment of Osteoarthritis Pain.

Huang J, Burston JJ, Li L, Ashraf S, Mapp PI, Bennett AJ, Ravipati S, Pousinis P, Barrett DA, Scammell BE, Chapman V.

Arthritis Rheumatol. 2017 May;69(5):996-1008. doi: 10.1002/art.40001.

5.

Robust anti-nociceptive effects of monoacylglycerol lipase inhibition in a model of osteoarthritis pain.

Burston JJ, Mapp PI, Sarmad S, Barrett DA, Niphakis MJ, Cravatt BF, Walsh DA, Chapman V.

Br J Pharmacol. 2016 Nov;173(21):3134-3144. doi: 10.1111/bph.13574. Epub 2016 Sep 23.

6.

The anti-NGF antibody muMab 911 both prevents and reverses pain behaviour and subchondral osteoclast numbers in a rat model of osteoarthritis pain.

Xu L, Nwosu LN, Burston JJ, Millns PJ, Sagar DR, Mapp PI, Meesawatsom P, Li L, Bennett AJ, Walsh DA, Chapman V.

Osteoarthritis Cartilage. 2016 Sep;24(9):1587-95. doi: 10.1016/j.joca.2016.05.015. Epub 2016 May 18.

7.

The role of the endocannabinoid system in pain.

Woodhams SG, Sagar DR, Burston JJ, Chapman V.

Handb Exp Pharmacol. 2015;227:119-43. doi: 10.1007/978-3-662-46450-2_7. Review.

PMID:
25846617
8.

Sex differences in Δ(9)-tetrahydrocannabinol metabolism and in vivo pharmacology following acute and repeated dosing in adolescent rats.

Wiley JL, Burston JJ.

Neurosci Lett. 2014 Jul 25;576:51-5. doi: 10.1016/j.neulet.2014.05.057. Epub 2014 Jun 5.

9.

Endocannabinoid contribution to Δ9-tetrahydrocannabinol discrimination in rodents.

Wiley JL, Walentiny DM, Wright MJ Jr, Beardsley PM, Burston JJ, Poklis JL, Lichtman AH, Vann RE.

Eur J Pharmacol. 2014 Aug 15;737:97-105. doi: 10.1016/j.ejphar.2014.05.013. Epub 2014 May 22.

10.

Cannabinoid CB2 receptors regulate central sensitization and pain responses associated with osteoarthritis of the knee joint.

Burston JJ, Sagar DR, Shao P, Bai M, King E, Brailsford L, Turner JM, Hathway GJ, Bennett AJ, Walsh DA, Kendall DA, Lichtman A, Chapman V.

PLoS One. 2013 Nov 25;8(11):e80440. doi: 10.1371/journal.pone.0080440. eCollection 2013.

11.

Increased function of pronociceptive TRPV1 at the level of the joint in a rat model of osteoarthritis pain.

Kelly S, Chapman RJ, Woodhams S, Sagar DR, Turner J, Burston JJ, Bullock C, Paton K, Huang J, Wong A, McWilliams DF, Okine BN, Barrett DA, Hathway GJ, Walsh DA, Chapman V.

Ann Rheum Dis. 2015 Jan;74(1):252-9. doi: 10.1136/annrheumdis-2013-203413. Epub 2013 Oct 23.

12.

Endocannabinoid system and pain: an introduction.

Burston JJ, Woodhams SG.

Proc Nutr Soc. 2014 Feb;73(1):106-17. doi: 10.1017/S0029665113003650. Epub 2013 Oct 22. Review.

PMID:
24148358
13.

Differences in structural and pain phenotypes in the sodium monoiodoacetate and meniscal transection models of osteoarthritis.

Mapp PI, Sagar DR, Ashraf S, Burston JJ, Suri S, Chapman V, Walsh DA.

Osteoarthritis Cartilage. 2013 Sep;21(9):1336-45. doi: 10.1016/j.joca.2013.06.031.

14.

Evaluation of NHS carbamates as a potent and selective class of endocannabinoid hydrolase inhibitors.

Niphakis MJ, Cognetta AB 3rd, Chang JW, Buczynski MW, Parsons LH, Byrne F, Burston JJ, Chapman V, Cravatt BF.

ACS Chem Neurosci. 2013 Sep 18;4(9):1322-32. doi: 10.1021/cn400116z. Epub 2013 Jun 17.

15.

Osteoprotegerin reduces the development of pain behaviour and joint pathology in a model of osteoarthritis.

Sagar DR, Ashraf S, Xu L, Burston JJ, Menhinick MR, Poulter CL, Bennett AJ, Walsh DA, Chapman V.

Ann Rheum Dis. 2014 Aug;73(8):1558-65. doi: 10.1136/annrheumdis-2013-203260. Epub 2013 May 30.

16.

Dynamic changes to the endocannabinoid system in models of chronic pain.

Rani Sagar D, Burston JJ, Woodhams SG, Chapman V.

Philos Trans R Soc Lond B Biol Sci. 2012 Dec 5;367(1607):3300-11. doi: 10.1098/rstb.2011.0390. Review.

17.

The contribution of spinal glial cells to chronic pain behaviour in the monosodium iodoacetate model of osteoarthritic pain.

Sagar DR, Burston JJ, Hathway GJ, Woodhams SG, Pearson RG, Bennett AJ, Kendall DA, Scammell BE, Chapman V.

Mol Pain. 2011 Nov 17;7:88. doi: 10.1186/1744-8069-7-88.

18.

Enhancement of the behavioral effects of endogenous and exogenous cannabinoid agonists by phenylmethyl sulfonyl fluoride.

Vann RE, Walentiny DM, Burston JJ, Tobey KM, Gamage TF, Wiley JL.

Neuropharmacology. 2012 Feb;62(2):1019-27. doi: 10.1016/j.neuropharm.2011.10.011. Epub 2011 Oct 31.

19.

Fish oil promotes survival and protects against cognitive decline in severely undernourished mice by normalizing satiety signals.

Avraham Y, Saidian M, Burston JJ, Mevorach R, Vorobiev L, Magen I, Kunkes E, Borges B, Lichtman AH, Berry EM.

J Nutr Biochem. 2011 Aug;22(8):766-76. doi: 10.1016/j.jnutbio.2010.07.001. Epub 2010 Dec 15.

20.

Chronic monoacylglycerol lipase blockade causes functional antagonism of the endocannabinoid system.

Schlosburg JE, Blankman JL, Long JZ, Nomura DK, Pan B, Kinsey SG, Nguyen PT, Ramesh D, Booker L, Burston JJ, Thomas EA, Selley DE, Sim-Selley LJ, Liu QS, Lichtman AH, Cravatt BF.

Nat Neurosci. 2010 Sep;13(9):1113-9. doi: 10.1038/nn.2616. Epub 2010 Aug 22.

21.

Regional enhancement of cannabinoid CB₁ receptor desensitization in female adolescent rats following repeated Delta-tetrahydrocannabinol exposure.

Burston JJ, Wiley JL, Craig AA, Selley DE, Sim-Selley LJ.

Br J Pharmacol. 2010 Sep;161(1):103-12. doi: 10.1111/j.1476-5381.2010.00870.x.

22.

Biochanin A, a naturally occurring inhibitor of fatty acid amide hydrolase.

Thors L, Burston JJ, Alter BJ, McKinney MK, Cravatt BF, Ross RA, Pertwee RG, Gereau RW 4th, Wiley JL, Fowler CJ.

Br J Pharmacol. 2010 Jun;160(3):549-60. doi: 10.1111/j.1476-5381.2010.00716.x.

23.

Chronic Delta9-tetrahydrocannabinol during adolescence increases sensitivity to subsequent cannabinoid effects in delayed nonmatch-to-position in rats.

Wiley JL, Burston JJ.

Pharmacol Biochem Behav. 2010 Feb;94(4):516-23. doi: 10.1016/j.pbb.2009.11.006. Epub 2009 Nov 24.

24.

Dual blockade of FAAH and MAGL identifies behavioral processes regulated by endocannabinoid crosstalk in vivo.

Long JZ, Nomura DK, Vann RE, Walentiny DM, Booker L, Jin X, Burston JJ, Sim-Selley LJ, Lichtman AH, Wiley JL, Cravatt BF.

Proc Natl Acad Sci U S A. 2009 Dec 1;106(48):20270-5. doi: 10.1073/pnas.0909411106. Epub 2009 Nov 16.

25.

Synthesis and pharmacological activity of a potent inhibitor of the biosynthesis of the endocannabinoid 2-arachidonoylglycerol.

Bisogno T, Burston JJ, Rai R, Allarà M, Saha B, Mahadevan A, Razdan RK, Wiley JL, Di Marzo V.

ChemMedChem. 2009 Jun;4(6):946-50. doi: 10.1002/cmdc.200800442.

PMID:
19266526
26.

Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects.

Long JZ, Li W, Booker L, Burston JJ, Kinsey SG, Schlosburg JE, Pavón FJ, Serrano AM, Selley DE, Parsons LH, Lichtman AH, Cravatt BF.

Nat Chem Biol. 2009 Jan;5(1):37-44. doi: 10.1038/nchembio.129. Epub 2008 Nov 23.

27.

Monoacylglycerol lipase regulates 2-arachidonoylglycerol action and arachidonic acid levels.

Nomura DK, Hudak CS, Ward AM, Burston JJ, Issa RS, Fisher KJ, Abood ME, Wiley JL, Lichtman AH, Casida JE.

Bioorg Med Chem Lett. 2008 Nov 15;18(22):5875-8. doi: 10.1016/j.bmcl.2008.08.007. Epub 2008 Aug 6.

28.

Antipsychotic-induced alterations in CB1 receptor-mediated G-protein signaling and in vivo pharmacology in rats.

Wiley JL, Kendler SH, Burston JJ, Howard DR, Selley DE, Sim-Selley LJ.

Neuropharmacology. 2008 Dec;55(7):1183-90. doi: 10.1016/j.neuropharm.2008.07.026. Epub 2008 Jul 30.

29.

N-arachidonyl maleimide potentiates the pharmacological and biochemical effects of the endocannabinoid 2-arachidonylglycerol through inhibition of monoacylglycerol lipase.

Burston JJ, Sim-Selley LJ, Harloe JP, Mahadevan A, Razdan RK, Selley DE, Wiley JL.

J Pharmacol Exp Ther. 2008 Nov;327(2):546-53. doi: 10.1124/jpet.108.141382. Epub 2008 Aug 5.

30.

CB1 cannabinoid receptor-mediated modulation of food intake in mice.

Wiley JL, Burston JJ, Leggett DC, Alekseeva OO, Razdan RK, Mahadevan A, Martin BR.

Br J Pharmacol. 2005 Jun;145(3):293-300.

31.

A discrete domain of the human TrkB receptor defines the binding sites for BDNF and NT-4.

Naylor RL, Robertson AG, Allen SJ, Sessions RB, Clarke AR, Mason GG, Burston JJ, Tyler SJ, Wilcock GK, Dawbarn D.

Biochem Biophys Res Commun. 2002 Mar 1;291(3):501-7.

PMID:
11855816

Supplemental Content

Loading ...
Support Center